Cargando…
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
Pulmonary arterial hypertension (PAH) is a rare disease leading to right heart failure and death. Prognosis remains poor, particularly for patients with severe disease, i.e. World Health Organization functional class IV. There have been significant improvements in treatment options. Several agents a...
Autores principales: | Corris, Paul, Degano, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487408/ https://www.ncbi.nlm.nih.gov/pubmed/25445947 http://dx.doi.org/10.1183/09059180.00007214 |
Ejemplares similares
-
The UK National Pulmonary Hypertension Service, Registry and Research Collaboration
por: Corris, Paul A
Publicado: (2015) -
Single Lung Transplant for Secondary Pulmonary Hypertension: The Right Option for the Right Patient
por: Housman, Brian, et al.
Publicado: (2023) -
MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension
por: Crimi, Gabriele, et al.
Publicado: (2018) -
Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019) -
Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)